MCID: ASP001
MIFTS: 50

Asperger Syndrome malady

Categories: Genetic diseases, Rare diseases, Mental diseases, Fetal diseases

Aliases & Classifications for Asperger Syndrome

About this section

Aliases & Descriptions for Asperger Syndrome:

Name: Asperger Syndrome 10 45 22 23 46 47 12 36 65
Asperger Disorder 45 22 23
Asperger's Syndrome 23 24
 
Asperger's Disorder 23
Asperger's Disease 23
Asperger Disease 23

Classifications:



External Ids:

Disease Ontology10 DOID:0050432
ICD1027 F84.5
MeSH36 D020817
NCIt42 C97159
UMLS65 C0236792

Summaries for Asperger Syndrome

About this section
NIH Rare Diseases:45 Asperger syndrome (as) is an autism spectrum disorder, a type of neurological condition characterized by impaired language and communication skills, and repetitive or restrictive thought and behavior patterns. unlike many people with autism, those with as retain their early language skills. features of as include an obsessive interest in a particular object or topic; high vocabulary; formal speech patterns; repetitive routines or habits; inappropriate social and emotional behavior; impaired non-verbal communication; and uncoordinated motor skills. as is likely caused by a combination of genetic and environmental influences. while autism spectrum disorders including as sometimes run in families, no specific inheritance pattern has been recognized. last updated: 6/8/2015

MalaCards based summary: Asperger Syndrome, also known as asperger disorder, is related to autism spectrum disorder and atypical autism. An important gene associated with Asperger Syndrome is NLGN4X (Neuroligin 4, X-Linked). Affiliated tissues include testes, brain and lung, and related mouse phenotypes are endocrine/exocrine gland and growth/size/body region.

Disease Ontology:10 An autism spectrum disorder that is characterized by significant difficulties in social interaction, along with restricted and repetitive patterns of behavior and interests. It differs from other autism spectrum disorders by its relative preservation of linguistic and cognitive development.

NINDS:46 Asperger syndrome (AS) is a developmental disorder.

Genetics Home Reference:23 Asperger syndrome is a disorder on the autism spectrum, which is a group of conditions characterized by impaired communication and social interaction. Asperger syndrome is on the mild, or "high-functioning," end of the autism spectrum. Many affected individuals learn to compensate for their differences and live independent and successful lives. However, the behavioral challenges associated with this condition often lead to social isolation and difficulties at school, at work, and in personal relationships.

Wikipedia:68 Asperger syndrome (AS), also known as Aspergers, is a developmental disorder characterized by... more...

Related Diseases for Asperger Syndrome

About this section

Diseases related to Asperger Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 49)
idRelated DiseaseScoreTop Affiliating Genes
1autism spectrum disorder29.5GABRB3, NLGN3, NLGN4X, OXTR, SLC25A12, SLC6A4
2atypical autism27.5DISC1, GABRB3, NLGN3, NLGN4X, OXTR, SHANK3
3asperger syndrome susceptibility, x-linked 112.2
4asperger syndrome susceptibility, x-linked 212.2
5schizophrenia10.2
6acute dacryocystitis10.1OXTR, SLC6A4
7learning disability10.1
8sexual disorder10.0NLGN3, NLGN4X
9autism susceptibility 1610.0
10autism 910.0
11autism susceptibility 1510.0
12autism 1010.0
13autism susceptibility 1710.0
14autism 1810.0
15autism susceptibility, x-linked 210.0
16autism x-linked 410.0
17autism susceptibility, x-linked 110.0
18autism susceptibility, x-linked 310.0
19autism x-linked 510.0
20epsilon-trimethyllysine hydroxylase deficiency10.0
21obsessive-compulsive disorder10.0
22personality disorder10.0
23prosopagnosia10.0
24attention deficit-hyperactivity disorder9.9
25specific language impairment9.9
26gender identity disorder9.9
27conduct disorder9.9
28myotonic dystrophy9.9
29pervasive developmental disorder9.9
30prader-willi syndrome9.8
31synesthesia9.7
32cystic fibrosis9.7
33anorexia nervosa9.7
34common variable immunodeficiency9.7
35crohn's disease9.7
36temporal lobe epilepsy9.7
37writing disorder9.7
38alexithymia9.7
39stuttering9.7
40borderline personality disorder9.7
41anxiety disorder9.7
42psychotic disorder9.7
43astrocytoma9.7
44mood disorder9.7
45cerebritis9.7
46cerebellar astrocytoma9.7
47opportunistic mycosis9.5DISC1, GABRB3, SHANK3, SLC6A4
48autoimmune hepatitis9.3GABRB3, NLGN3, NLGN4X, OXTR, SLC6A4
49usher syndrome5.7ARNT2, AVPR1B, CYP11B1, DISC1, GABRB3, NLGN3

Graphical network of the top 20 diseases related to Asperger Syndrome:



Diseases related to asperger syndrome

Symptoms for Asperger Syndrome

About this section

Drugs & Therapeutics for Asperger Syndrome

About this section

Drugs for Asperger Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 98)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DopamineapprovedPhase 4, Phase 3, Phase 2308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
2
Methylphenidateapproved, investigationalPhase 4364113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
Methyl phenidyl acetate
 
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate Hydrochloride
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Quillivant XR
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
3
Guanfacineapproved, investigationalPhase 45329110-47-23519
Synonyms:
29110-47-2
29110-48-3 (mono-hydrochloride)
AC1L1G4B
BPBio1_000415
BRD-K32830106-003-03-0
BSPBio_000377
C07037
C9H9Cl2N3O
CAS-29110-48-3
CHEMBL862
CID3519
D08031
DB01018
EINECS 249-442-8
Estulic
Estulic (TN)
G1043_SIGMA
GUANFACINE
Guanfacina
Guanfacina [INN-Spanish]
Guanfacine
Guanfacine (INN)
Guanfacine Hydrochloride
Guanfacine Monohydrochloride
Guanfacine [INN:BAN]
Guanfacinum
 
Guanfacinum [INN-Latin]
Intuniv
L000286
L013430
LS-174236
Lon798
Lopac-G-1043
Lopac0_000519
MolPort-003-941-447
N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide
NCGC00015469-01
NCGC00015469-02
NCGC00015469-06
NCGC00024950-01
NCGC00024950-02
NCGC00024950-03
Prestwick0_000339
Prestwick1_000339
Prestwick2_000339
Prestwick3_000339
SPBio_002298
SPD 503
Tenex
Tocris-1030
UNII-30OMY4G3MK
ZINC03872738
4
MilnacipranapprovedPhase 45892623-85-365833
Synonyms:
( -)-Milnacipran
(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
(-)-milnacipran
(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl
105310-09-6
92623-85-3
AC1L2425
CHEMBL252923
CID65833
D08222
DB04896
F 2207
F-2207
 
F2207
Ixel
LS-178180
Midalcipran
Milnacipran
Milnacipran (INN)
Milnacipran Hydrochloride
Milnacipran [INN]
Milnacipranum
Milnacipranum [Latin]
Milnacipranum [latin]
NCGC00165825-01
Savella
Toledomin
UNII-G56VK1HF36
milnacipran
5
Risperidoneapproved, investigationalPhase 4, Phase 3477106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
NCGC00015883-01
 
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperdal M-tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone M-tab
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
6
Cholineapproved, nutraceuticalPhase 413062-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
7
Creatineapproved, nutraceuticalPhase 411057-00-1586
Synonyms:
((amino(Imino)methyl)(methyl)amino)acetic acid
((amino(imino)methyl)(methyl)amino)acetate
((amino(imino)methyl)(methyl)amino)acetic acid
(N-methylcarbamimidamido)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(α-methylguanido)acetic acid
Cosmocair C 100
Creatin
Creatine
Creatine hydrate
Kreatin
 
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-Methyl-Glycine
N-(aminoiminomethyl)-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
Phosphagen
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetic acid
8Tranquilizing AgentsPhase 4, Phase 3, Phase 23597
9Atomoxetine HydrochloridePhase 4, Phase 3160
10Adrenergic alpha-2 Receptor AgonistsPhase 4790
11Adrenergic AgentsPhase 4, Phase 3, Phase 24204
12Antihypertensive AgentsPhase 43618
13Adrenergic alpha-AgonistsPhase 41300
14
PhosphocreatinePhase 4667-07-2587
Synonyms:
Creatine phosphate
Creatine-P
Creatine-phosphate
Creatinephosphoric acid
N-(Phosphonoamidino)-Sarcosine
N-(Phosphonoamidino)sarcosine
 
N-Phosphocreatine
N-Phosphorocreatine
N-Phosphorylcreatine
N-[Imino(phosphonoamino)methyl]-N-methyl-Glycine
Neo-ton
P-Creatine
Phosphocreatine
Phosphorylcreatine
15Adrenergic AgonistsPhase 42331
16Serotonin AntagonistsPhase 4, Phase 3, Phase 21175
17Psychotropic DrugsPhase 4, Phase 3, Phase 25501
18
SerotoninPhase 4, Phase 3, Phase 2314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
19Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 22857
20Dopamine AntagonistsPhase 4, Phase 3, Phase 2927
21Antidepressive AgentsPhase 4, Phase 3, Phase 22367
22Serotonin AgentsPhase 4, Phase 3, Phase 22668
23Neurotransmitter AgentsPhase 4, Phase 3, Phase 214795
24Serotonin Uptake InhibitorsPhase 4, Phase 21369
25Central Nervous System DepressantsPhase 4, Phase 3, Phase 210016
26Dopamine AgentsPhase 4, Phase 3, Phase 23084
27Antipsychotic AgentsPhase 4, Phase 3, Phase 22130
28Dopamine Uptake InhibitorsPhase 4925
29Central Nervous System StimulantsPhase 41721
30Rho(D) Immune GlobulinPhase 4206
31Immunologic FactorsPhase 418483
32ImmunoglobulinsPhase 44477
33Immunoglobulins, IntravenousPhase 4211
34AntibodiesPhase 44477
35
CycloserineapprovedPhase 310368-41-7401, 6234
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-Cycloserine
1pb9
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, D
30020_FLUKA
30020_SIGMA
4-27-00-05549 (Beilstein Handbook Reference)
4AX
68-41-7
AB00443920
AC-4721
AC1L1M33
AC1Q4UA7
AI3-50153
BB_NC-1631
BIDD:GT0707
BPBio1_001252
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
C3909_SIGMA
C3H6N2O2
C6880_SIGMA
C7670_SIGMA
CAS-339-72-0
CAS-68-41-7
CHEBI:40009
CHEMBL771
CID6234
CPD-2482
CPD000058313
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
Cyclo-D-serine
Cyclorin
Cycloserine
Cycloserine (JP15/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-Isoxazolidinone
D-4-amino-3-Isoxazolidone
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-CS
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D-amino-3-isoxazolidinone
D-cycloserine
D00877
DB03123
DCS
DL-Cycloserine
DRG-0195
DivK1c_000098
E-733-A
EINECS 200-688-4
 
EU-0100252
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS500E20
HSDB 3218
I-1431
IDI1_000098
K-300
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
L-Cycloserine
LMPK14000007
LS-86757
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
MLS000758215
MLS001423962
Micoserina
Miroserina
Miroseryn
MolPort-000-858-643
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-05
NCGC00093713-01
NCGC00093713-02
NINDS_000098
NSC 154851
Novoserin
Orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
R(+)-4-Amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
RO-1-9213
Ro-1-9213
S1998_Selleck
SAM001247014
SAM002264599
SC-49088
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
SPECTRUM1500215
Seromycin
Seromycin (TN)
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
Spectrum_000860
Tebemicina
Tisomycin
UNII-95IK5KI84Z
Wasserina
alpha-Cycloserine
cyclo-D-Serine
cycloserine
orientomycin
α-Cycloserine
36
MianserinapprovedPhase 33324219-97-44184
Synonyms:
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
21535-47-7 (mono-hydrochloride)
24219-97-4
AC-631
AC1L1HLP
BPBio1_000064
BPBio1_000331
BRD-A19661776-001-01-5
BRD-A19661776-003-05-2
BRN 0755346
BSPBio_000058
BSPBio_003511
Biomol-NT_000135
Bolvidon
C18H20N2
CHEBI:51137
CHEMBL6437
CID4184
D08216
DB06148
DivK1c_000844
EINECS 246-088-6
HMS2089A04
HSDB 7182
IDI1_000844
KBio1_000844
KBio2_002301
KBio2_004869
KBio2_007437
KBio3_003016
KBioGR_001820
KBioSS_002303
L000736
LS-61197
Lopac0_000744
Mianserin (INN)
 
Mianserin Monohydrochloride
Mianserin [INN:BAN]
Mianserin hydrochloride
Mianserina
Mianserina [INN-Spanish]
Mianserina [inn-spanish]
Mianserine
Mianserine [INN-French]
Mianserine [inn-french]
Mianserinum
Mianserinum [INN-Latin]
Mianserinum [inn-latin]
Mianseryna
Mianseryna [Polish]
Mianseryna [polish]
MolPort-003-849-215
NCGC00015656-09
NCGC00024926-03
NCGC00024926-04
NINDS_000844
Norval
Oprea1_703627
PDSP1_001532
PDSP2_001516
Prestwick0_000099
Prestwick1_000099
Prestwick2_000099
Prestwick3_000099
SPBio_000986
SPBio_001997
Spectrum2_001203
Spectrum3_001836
Spectrum4_001260
Spectrum5_001772
Spectrum_001810
Tolvan
Tolvon
Tolvon (TN)
mianserin
37
ZiprasidoneapprovedPhase 3140146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone Hydrochloride
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
38
MirtazapineapprovedPhase 37885650-52-8, 61337-67-54205
Synonyms:
(1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
(N-methyl-11C)mirtazapine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
6-Azamianserin
61337-67-5
82601-27-2
85650-52-8
AC-15480
AC1L1HND
AC1Q3ZYM
Avanza
Axit
Azamianserin
BRD-A64977602-001-01-9
C035133
C07570
CHEBI:6950
CHEMBL654
CID4205
CPD000466347
Celltech brand of mirtazapine
D00563
DB00370
EINECS 288-060-6
HMS2052H03
I01-1882
I06-0606
L001294
LS-127703
LS-185067
M0443_SIGMA
ME-2040
MLS000759460
MLS001076676
Mepirzapin
Mepirzapine
 
Mepirzepine
Mirtabene
Mirtaz
Mirtazapin
Mirtazapina
Mirtazapina [INN-Spanish]
Mirtazapine
Mirtazapine (JAN/USAN/INN)
Mirtazapine [USAN:BAN:INN]
Mirtazapine [USAN:INN:BAN]
Mirtazapine [Usan:Ban:Inn]
Mirtazapinum
Mirtazapinum [INN-Latin]
Mirtazepine
Mirtazipine
Mirtazon
MolPort-003-849-233
Mundogen brand of mirtazapine
NCGC00025346-02
Norset
ORG 3770
Org-3770
Organon brand of mirtazapine
PDSP1_001529
PDSP2_001513
Promyrtil
Remergil
Remergon
Remeron
Remeron (TN)
Remeron SolTab
Remeron Soltab
Remeronsoltab
Rexer
SAM001246659
SMR000466347
STK711107
UNII-A051Q2099Q
Zispin
mirtazapine
39
Histamine PhosphateapprovedPhase 390651-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
 
H0147
Histamine Positive Skin Test Control
Histamine Positive skin test control
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
40Anti-Bacterial AgentsPhase 39140
41Antibiotics, AntitubercularPhase 35971
42Anti-Infective AgentsPhase 3, Phase 217220
43Contraceptives, OralPhase 3, Phase 23734
44Antidepressive Agents, Second-GenerationPhase 3, Phase 21087
45Antitubercular AgentsPhase 31061
46Adrenergic alpha-AntagonistsPhase 3, Phase 2586
47Adrenergic AntagonistsPhase 3, Phase 21253
48AntimetabolitesPhase 39454
49Histamine H1 AntagonistsPhase 3688
50Antidepressive Agents, TricyclicPhase 3250

Interventional clinical trials:

(show top 50)    (show all 75)
idNameStatusNCT IDPhase
1Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of AutismCompletedNCT01337700Phase 4
2Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone StudyCompletedNCT00352196Phase 4
3Atomoxetine, Placebo and Parent Management Training in AutismCompletedNCT00844753Phase 4
4Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental DisorderCompletedNCT01238575Phase 4
5Understanding the Effects of Intervention on the Brain in AutismRecruitingNCT02680015Phase 4
6Methylphenidate ER Liquid Formulation in Adults With ASD and ADHDRecruitingNCT02096952Phase 4
7An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism SpectrumActive, not recruitingNCT02199925Phase 4
8Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01178385Phase 2, Phase 3
9A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)CompletedNCT00261508Phase 3
10D-Cycloserine and Social Skills Training in Autism Spectrum DisordersCompletedNCT01086475Phase 3
11Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02028247Phase 3
12Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02111395Phase 3
13Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental DisordersRecruitingNCT01302964Phase 3
14Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismRecruitingNCT00498173Phase 3
15An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)CompletedNCT01592786Phase 2
16Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With MemantineCompletedNCT01592747Phase 2
17CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOSCompletedNCT00280670Phase 2
18The Development of Autistic Children Based on Mothers´Response in Autism Behavior ChecklistCompletedNCT00725556Phase 1, Phase 2
19Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for AdolescentsCompletedNCT01177969Phase 1, Phase 2
20A Study of Oral N-Acetylcysteine in Children With Autism Spectrum DisordersCompletedNCT00453180Phase 2
21A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.CompletedNCT00198055Phase 2
22Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2
23Study of Aripiprazole to Treat Children and Adolescents With AutismCompletedNCT00619190Phase 2
24My Scrivener® - Measuring Effectiveness and Dose Response in ChildrenCompletedNCT00919906Phase 1, Phase 2
25Cholesterol in ASD: Characterization and TreatmentCompletedNCT00965068Phase 1, Phase 2
26Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2
27An Open-Label Trial of Aripiprazole in Autism Spectrum DisordersCompletedNCT00308074Phase 2
28Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum DisordersCompletedNCT01288716Phase 2
29Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)CompletedNCT00086645Phase 2
30Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)CompletedNCT01248728Phase 2
31Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.RecruitingNCT01388179Phase 2
32Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)TerminatedNCT01592773Phase 2
33A Folinic Acid Intervention for Autism Spectrum DisordersTerminatedNCT01602016Phase 2
34Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in AutismTerminatedNCT01983189Phase 2
35Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
36Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and AnxietyCompletedNCT01187784Phase 1
37A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's SyndromeCompletedNCT01669889
38The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's DisorderCompletedNCT00808782
39Advanced Grandparental Age as a Risk Factor for AutismCompletedNCT00464477
40Psychometric Studies of the Chinese Versions of the SRS, CAST, and AQCompletedNCT01247662
41Cognitive Behavioural Therapy (CBT) and Recreational Activity for Autism Spectrum Disorders (ASD)CompletedNCT01655173
42Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With AutismCompletedNCT01563003
43Predictors of Caregiver Adaptation to Pervasive Developmental DisordersCompletedNCT00496210
44Shared Decision Making to Improve Care and Outcomes for Children With AutismCompletedNCT01921244
45Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in AutismCompletedNCT00211783
46GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education ProgramsCompletedNCT01808066
47Intranasal Oxytocin for the Treatment of Autism Spectrum DisordersCompletedNCT01337687
48Neural and Behavioral Outcomes of Social Skills Groups in Children With Autism Spectrum Disorder (ASD)CompletedNCT01190917
49RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental DisordersCompletedNCT00080145
50Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum DisordersCompletedNCT01361503

Search NIH Clinical Center for Asperger Syndrome


Cochrane evidence based reviews: asperger syndrome

Genetic Tests for Asperger Syndrome

About this section

Genetic tests related to Asperger Syndrome:

id Genetic test Affiliating Genes
1 Asperger Disorder22

Anatomical Context for Asperger Syndrome

About this section

MalaCards organs/tissues related to Asperger Syndrome:

33
Testes, Brain, Lung, Breast, Prostate, Heart, B cells

Animal Models for Asperger Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Asperger Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053797.7ARNT2, AVPR1B, CYP11B1, OXTR, SLC6A4, WFS1
2MP:00053786.8CYP11B1, DISC1, GABRB3, NLGN3, OXTR, SHANK3
3MP:00036316.5ARNT2, AVPR1B, DISC1, GABRB3, NLGN3, OXTR
4MP:00053865.8AVPR1B, CYP11B1, DISC1, GABRB3, NLGN3, OXTR

Publications for Asperger Syndrome

About this section

Articles related to Asperger Syndrome:

(show top 50)    (show all 464)
idTitleAuthorsYear
1
Do Adults with High Functioning Autism or Asperger Syndrome Differ in Empathy and Emotion Recognition? (26883645)
2016
2
Romantic Relationships and Relationship Satisfaction Among Adults With Asperger Syndrome and High-Functioning Autism. (27196958)
2016
3
I Collect Therefore I am-Autonoetic Consciousness and Hoarding in Asperger Syndrome. (24615808)
2014
4
The neuropsychology of male adults with high-functioning autism or asperger syndrome. (24903974)
2014
5
Neurological abnormalities in recent-onset schizophrenia and asperger-syndrome. (25147527)
2014
6
Asperger syndrome related suicidal behavior: two case studies. (24294002)
2013
7
Early identification of Asperger syndrome in young children. (23123877)
2013
8
Motor examination in children with Attention-deficit/hyperactivity Disorder and Asperger Syndrome. (21824190)
2012
9
Narrative competence and internal state language of children with Asperger Syndrome and ADHD. (22522198)
2012
10
"We are all there silently coping." The hidden experiences of parents of adults with Asperger syndrome. (22852754)
2012
11
Mosaic partial trisomy 19p12-q13.11 due to a small supernumerary marker chromosome: a locus associated with Asperger syndrome? (21815264)
2011
12
Asperger syndrome and the supposed obligation not to bring disabled lives into the world. (20675739)
2010
13
Executive functioning in children with Asperger syndrome, ADHD-combined type, ADHD-predominately inattentive type, and controls. (20140638)
2010
14
Asperger syndrome in adolescent and young adult males. Interview, self- and parent assessment of social, emotional, and cognitive problems. (19880274)
2010
15
Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study. (20177765)
2010
16
Asperger syndrome, violent thoughts and clinically isolated syndrome. (21305864)
2010
17
A descriptive social and health profile of a community sample of adults and adolescents with Asperger syndrome. (21070680)
2010
18
Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging. (20952166)
2010
19
Pragmatic inferences in high-functioning adults with autism and Asperger syndrome. (19052858)
2009
20
The anatomy of extended limbic pathways in Asperger syndrome: a preliminary diffusion tensor imaging tractography study. (19446642)
2009
21
Social challenges and supports from the perspective of individuals with Asperger syndrome and other autism spectrum disabilities. (18308766)
2008
22
Exploring the relationship between measures of self-esteem and psychological adjustment among adolescents with Asperger syndrome. (18579646)
2008
23
Sleep in children with Asperger syndrome. (17340201)
2008
24
Disembedding performance in children and adolescents with Asperger syndrome or high-functioning autism. (17175576)
2007
25
Answering contextually demanding questions: pragmatic errors produced by children with Asperger syndrome or high-functioning autism. (17126362)
2007
26
Autobiographical memory and social problem-solving in Asperger syndrome. (16874561)
2007
27
Brief report: social and communication abilities and disabilities in higher functioning individuals with autism and Asperger syndrome. (17160458)
2007
28
Effects of vagus nerve stimulation in a patient with temporal lobe epilepsy and Asperger syndrome: case report and review of the literature. (17300990)
2007
29
Sleep architecture and NREM alterations in children and adolescents with Asperger syndrome. (18041490)
2007
30
Sleep patterns of school-age children with Asperger syndrome or high-functioning autism. (16617404)
2006
31
Independent replication and initial fine mapping of 3p21-24 in Asperger syndrome. (16467216)
2006
32
Monozygotic twins with Asperger syndrome: differences in behaviour reflect variations in brain structure and function. (16459007)
2006
33
Diagnosis of Asperger syndrome in a 66-year-old male presenting with depression. (16734928)
2006
34
The Strange Stories test--a replication study of children and adolescents with Asperger syndrome. (15793686)
2005
35
An experimental investigation of the phenomenology of delusional beliefs in people with Asperger syndrome. (16287703)
2005
36
Higher plasma ACTH levels in adults with Asperger syndrome. (16125520)
2005
37
Finding meaning in parenting a child with Asperger syndrome: correlates of sense making and benefit finding. (15134791)
2004
38
Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and Asperger syndrome. (12708575)
2003
39
Deficient auditory processing in children with Asperger Syndrome, as indexed by event-related potentials. (12581830)
2003
40
Outcome research in Asperger syndrome and autism. (12512398)
2003
41
Psychosocial functioning in a group of Swedish adults with Asperger syndrome or high-functioning autism. (12638767)
2003
42
Misdiagnosis of Asperger syndrome as anankastic personality disorder. (12540134)
2002
43
Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. (12365875)
2002
44
Temperament and character in adults with Asperger syndrome. (12212919)
2002
45
Asperger syndrome: tests of right hemisphere functioning and interhemispheric communication. (12199132)
2002
46
Speech and prosody characteristics of adolescents and adults with high-functioning autism and Asperger syndrome. (11708530)
2001
47
The Strange Stories Test: a replication with high-functioning adults with autism or Asperger syndrome. (10587886)
1999
48
Brief report: autism and Asperger syndrome in seven-year-old children: a total population study. (10478732)
1999
49
Recognition of faux pas by normally developing children and children with Asperger syndrome or high-functioning autism. (10587887)
1999
50

Variations for Asperger Syndrome

About this section

Expression for genes affiliated with Asperger Syndrome

About this section
Search GEO for disease gene expression data for Asperger Syndrome.

Pathways for genes affiliated with Asperger Syndrome

About this section

GO Terms for genes affiliated with Asperger Syndrome

About this section

Cellular components related to Asperger Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1synapseGO:00452029.6GABRB3, NLGN3, NLGN4X
2dendriteGO:00304258.7NLGN3, NLGN4X, SGCE, WFS1

Biological processes related to Asperger Syndrome according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1postsynaptic membrane assemblyGO:009710410.3NLGN3, NLGN4X
2presynaptic membrane assemblyGO:009710510.3NLGN3, NLGN4X
3positive regulation of excitatory postsynaptic potentialGO:200046310.3NLGN3, SHANK3
4neuron cell-cell adhesionGO:000715810.3NLGN3, NLGN4X
5vocalization behaviorGO:007162510.3NLGN3, SHANK3
6sperm ejaculationGO:004271310.0OXTR, SLC6A4
7positive regulation of synapse assemblyGO:005196510.0NLGN3, OXTR
8adult behaviorGO:00305349.9NLGN3, NLGN4X, SHANK3
9learningGO:00076129.9NLGN3, SHANK3
10memoryGO:00076139.8SHANK3, SLC6A4
11sensory perception of soundGO:00076059.6GABRB3, WFS1
12positive regulation of synaptic transmission, glutamatergicGO:00519689.6NLGN3, OXTR, SHANK3
13social behaviorGO:00351769.5NLGN3, OXTR

Molecular functions related to Asperger Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neurexin family protein bindingGO:004204310.0NLGN3, NLGN4X

Sources for Asperger Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet